Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD5024 versus metronidazole cream in papulopustular rosacea
2008-003854-13Phase 3Active
- Sponsor
- Galderma
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ivermectin and metronidazole in papulopustular rosacea and rosacea (2 arms), sponsored by Galderma. Primary endpoint: Percent change in inflammatory lesions from baseline to Week 16. Started Nov 2008; status: active.
02
Drugs
ivermectinmetronidazole
03
Conditions
papulopustular rosacearosacea
Beyond the preview
Go deeper on 2008-003854-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003854-13.